Tai‐Ping Fan
Biographic Data
| ID | 10913032 |
|---|---|
| NAME | Tai‐Ping Fan |
| GIVEN NAMES | Tai‐Ping |
| FAMILY NAME | Fan |
| SIGNATURE | FAN T P |
| AFFILIATIONS | University of Cambridge |
| ORCID | 0000-0003-1000-5369 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 0 |
Omics and its potential impact on R&D and regulation of complex herbal products
In traditional Chinese medicine (TCM), multicomponent and principally plant-derived drugs are used for disease prevention, symptom amelioration and treatment in a personalized manner. Because of their complex composition and consequent multiple targets and treatment objectives, the application of omics techniques and other integrative approaches seems inherently appropriate and even necessary for the demonstration of their potential preclinical a…
Future development of global regulations of Chinese herbal products
ETHNOPHARMACOLOGICAL RELEVANCE: GP-TCM is the first EU-funded Coordination Action consortium dedicated to traditional Chinese medicine (TCM) research. One of the key deliverables of the Work Package 7 in GP-TCM was to investigate information of the existing requirements for registration of TCM products listed by global regulatory bodies. The paper aims to collate data and draw comparison of these regulations. Case studies are also presented to il…
No prominent works on this page.
Omics and its potential impact on R&D and regulation of complex herbal products
In traditional Chinese medicine (TCM), multicomponent and principally plant-derived drugs are used for disease prevention, symptom amelioration and treatment in a personalized manner. Because of their complex composition and consequent multiple targets and treatment objectives, the application of omics techniques and other integrative approaches seems inherently appropriate and even necessary for the demonstration of their potential preclinical a…
Future development of global regulations of Chinese herbal products
ETHNOPHARMACOLOGICAL RELEVANCE: GP-TCM is the first EU-funded Coordination Action consortium dedicated to traditional Chinese medicine (TCM) research. One of the key deliverables of the Work Package 7 in GP-TCM was to investigate information of the existing requirements for registration of TCM products listed by global regulatory bodies. The paper aims to collate data and draw comparison of these regulations. Case studies are also presented to il…
Alternative medicine (2 works) · Medicine (2 works) · Traditional Chinese Medicine Analysis (2 works) · Bioinformatics (1 work) · Biology (1 work) · Business (1 work) · China (1 work) · Complementary and Alternative Medicine Studies (1 work) · Computational biology (1 work) · Computational Drug Discovery Methods (1 work)